Advent Capital Management’s Evolent Health EVH Stock Holding History

Advent Capital Management’s Portfolio EVH Stock Details EVH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-10,000	Closed	-$200K	–	224
2018 Q4	$200K	Sell	10,000 -14,800	-60%	-$342K	﹤0.01%	185
2018 Q3	$704K	Buy	+24,800	New	+$592K	0.01%	191

Other funds holding EVH

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Advent Capital Management's EVH Position: Q1 2019 in Review

Advent Capital Management sold out of Evolent Health (EVH) in Q1 2019, closing a stake of 10,000 shares — an estimated $200K sold.

Advent Capital Management first reported a position in EVH in Q3 2018 and held it in 2 quarters. The position peaked at $704K in Q3 2018. 192 funds tracked by Wall St. Rank hold EVH as of Q1 2019.

Advent Capital Management reported no remaining Evolent Health position as of Q1 2019 after selling out during the quarter.
Advent Capital Management sold 10,000 Evolent Health shares in Q1 2019, an estimated $200K.
Advent Capital Management first reported a position in Evolent Health in Q3 2018 and held it in 2 quarters.
Advent Capital Management's Evolent Health position peaked at $704K in Q3 2018.
192 funds tracked by Wall St. Rank held Evolent Health as of Q1 2019.

Based on Advent Capital Management's 13F filing for Q1 2019, filed 15 May 2019.